Basket | Login | Register


WP10: Communication, dissemination and ethics

Work Packages

Pharmacog Logo

Main Objectives

This project is designed as a horizontal support WP for the whole project, in order to maximize the project impact and raise awareness on its outputs and results.

This WP will also support to the consortium on any issues related to communication, dissemination and ethics. This WP is organized around three main aims:

  1. To effectively communicate the progress of the project to a wide range of stakeholders, including researchers and scientists, people with dementia, their carers and relatives, Alzheimer associations, as well as policy makers on a European and national level.
  2. To launch the project and disseminate the project results to the general public, while contributing to raise awareness on issues directly related to the project such as genetic testing, the involvement of people with dementia in research and informed consent procedures.
  3. To initiate guidance, develop consensual approaches and provide guidance on ethical issues regarding dementia research including informed consent and genetic.

WP Leads

Academic lead: Jean Georges (Alzheimer Europe)

Industrial lead : Bruno Boutouyrie (Roche)

WP Partners

Alzheimer Europe and each PharmaCog Partners



Last Updated: Thursday 14 October 2010


  • Acknowledgements

    The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) for the Innovative Medicine Initiative under Grant Agreement No 115009.
  • Innovative Medicines Initiative
  • European Union
  • European Federation of Pharmaceutical Industries and Associations